Remove 2016 Remove Clinical Trials Remove Events Remove Programs
article thumbnail

Cannabis laws in Japan: Is weed legal?

The Cannigma

Since 2016, the country has permitted the sale of CBD and some Japanese companies produce cannabidiol products as well. Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. Shutterstock). Who can get medical cannabis in Japan?

Law 137
article thumbnail

Meredith Fisher-Corn, MD…….”Are You Able to Answer Your Patients’ Medical Marijuana Questions”

TheAnswerPage

According to state laws, in order to purchase medical marijuana products, a patient must first obtain a recommendation (not a prescription) for medical marijuana from a clinician and enroll in the state medical marijuana program. Since 2009, Dr. Fisher-Corn has served as Editor-in-Chief of TheAnswerPage.com.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Dalrada Corporation Expands Presence in Top Three Growth Industries: Clean Energy, Healthcare, Technology (IT)

Cannabis Law Report

According to Fundera, these industries anticipate 115 – 121% job growth over ten years (2016-2026). Prakat swiftly modernizes legacy business hardware, software programs, and downloadable apps. The second phase of cerVIA™ clinical trials in India is complete, with white paper submissions underway.

article thumbnail

First ethics at MAPS in question and now Australia’s Mind Medicine look to have some serious integrity issues too

Cannabis Law Report

Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. She was Founder and Executive Producer of the award-winning future-shaping events series, Creative Innovation Global.

article thumbnail

Psychedelic Science Leader Eleusis to Become Public Company in Merger with Silver Spike Acquisition Corp. II

Cannabis Law Report

ELE-Psilo program expected to enter clinical trials in Q2 2022 and to target the pressing need for rapid-acting antidepressants compatible with existing healthcare infrastructure and insurance. Eleusis secured an Innovation Passport Designation for ELE-Psilo in adult treatment-resistant depression under the U.K.

Therapy 52
article thumbnail

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. The MDMA Therapy Training Program was created to train the next generation of psychedelic therapists. Rick Doblin, Ph.D.,

article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. David joined the faculty at UC Davis in 2015, where he established a research program at the interface of chemistry and neuroscience.